APA (7th ed.) Citation

Mariko Ogawa‐Momohara, Yoshinao Muro, Takuya Takeichi, & Masashi Akiyama. (2020). Reducing immunosuppressant use in patients with chronic inflammation during the COVID‐19 pandemic: Risks versus benefits. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Mariko Ogawa‐Momohara, Yoshinao Muro, Takuya Takeichi, and Masashi Akiyama. Reducing Immunosuppressant Use in Patients with Chronic Inflammation During the COVID‐19 Pandemic: Risks Versus Benefits. Frontiers Media S.A., 2020.

MLA (9th ed.) Citation

Mariko Ogawa‐Momohara, et al. Reducing Immunosuppressant Use in Patients with Chronic Inflammation During the COVID‐19 Pandemic: Risks Versus Benefits. Frontiers Media S.A., 2020.